Our Cancer Precision Medicine Research Program:
Sequences tumors from high-risk solid tumor and hematological malignancy patients in collaboration with Ashion Analytics, a Certified Authorization Professional (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical genomics testing laboratory based in Phoenix, AZ.
- Conducts a bimonthly multidisciplinary Molecular Tumor Board to discuss sequencing results with clinicians, pathologists and basic scientists.
- Researches new precision medicine approaches in the areas of brain tumors, solid tumors, and leukemia and lymphoma.
Click the button below for more information about our program and research.